id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1994-P-0043-0007,FDA,FDA-1994-P-0043,FDA,Notice,NPR-Notice of Proposed Rule-Making,1995-12-28T05:00:00Z,1995,12,1995-12-28T05:00:00Z,1996-03-21T04:59:59Z,2008-05-16T23:21:21Z,,0,0,09000064804ff4ac
FDA-1994-P-0043-0006,FDA,FDA-1994-P-0043,FDA,Notice,NPR-Notice of Proposed Rule-Making,1995-12-28T05:00:00Z,1995,12,1995-12-28T05:00:00Z,1996-03-21T04:59:59Z,2008-05-16T23:21:15Z,,0,0,09000064804ff4ab
FDA-1994-P-0043-0008,FDA,FDA-1994-P-0043,FDA,Notice,NPR-Notice of Proposed Rule-Making,1995-12-28T05:00:00Z,1995,12,1995-12-28T05:00:00Z,1996-03-21T04:59:59Z,2008-05-16T23:21:16Z,,0,0,09000064804ff4ad
FDA-1994-P-0043-0004,FDA,FDA-1994-P-0043,FDA,Notice,NPR-Notice of Proposed Rule-Making,1995-12-28T05:00:00Z,1995,12,1995-12-28T05:00:00Z,1996-03-21T04:59:59Z,2008-05-16T23:21:16Z,,0,0,09000064804ff4a9
FDA-1994-P-0043-0010,FDA,FDA-1994-P-0043,FDA,Notice,NPR-Notice of Proposed Rule-Making,1995-12-28T05:00:00Z,1995,12,1995-12-28T05:00:00Z,1996-03-21T04:59:59Z,2008-05-16T23:21:18Z,,0,0,09000064804ff4af
FDA-1994-P-0043-0005,FDA,FDA-1994-P-0043,FDA,Notice,NPR-Notice of Proposed Rule-Making,1995-12-28T05:00:00Z,1995,12,1995-12-28T05:00:00Z,1996-03-21T04:59:59Z,2008-05-16T23:21:21Z,,0,0,09000064804ff4aa
FDA-1994-P-0043-0009,FDA,FDA-1994-P-0043,FDA,Notice,NPR-Notice of Proposed Rule-Making,1995-12-28T05:00:00Z,1995,12,1995-12-28T05:00:00Z,1996-03-21T04:59:59Z,2008-05-16T23:21:21Z,,0,0,09000064804ff4ae
FDA-1978-N-2157-0006,FDA,FDA-1978-N-2157,Acknowledgement Letter FDA/DDM to The Proctor & Gamble Company,Other,Acknowledgement Letter/Receipt,1995-12-22T05:00:00Z,1995,12,,,2019-08-01T18:37:54Z,,0,0,09000064805a6715
FDA-1978-N-2157-0004,FDA,FDA-1978-N-2157,"Acknowledgement Letter FDA/DDM to Huls America, Inc.",Other,Acknowledgement Letter/Receipt,1995-12-22T05:00:00Z,1995,12,,,2019-08-01T18:45:05Z,,0,0,09000064805a6713
FDA-1978-N-2157-0005,FDA,FDA-1978-N-2157,"Acknowledgment Letter from FDA/DDM to Smith & Nephew United Inc. re: Citizen Petition from Smith & Nephew United, Inc.",Other,Acknowledgement Letter/Receipt,1995-12-22T05:00:00Z,1995,12,,,2019-06-03T13:50:38Z,,0,0,09000064805a6714
FDA-1980-N-0074-0035,FDA,FDA-1980-N-0074,FDA,Notice,NCR-Notice of Correction,1995-12-05T05:00:00Z,1995,12,,,2008-05-30T22:53:09Z,,0,0,09000064805bb3ca
FDA-1993-N-0064-0002,FDA,FDA-1993-N-0064,FDA,Notice,NEC-Notice of Extension,1995-12-05T05:00:00Z,1995,12,1995-11-24T05:00:00Z,1995-12-23T04:59:59Z,2008-05-16T23:24:21Z,,0,0,09000064804fca32
FDA-1993-N-0064-0001,FDA,FDA-1993-N-0064,FDA,Notice,NEC-Notice of Extension,1995-12-05T05:00:00Z,1995,12,1995-11-24T05:00:00Z,1995-12-23T04:59:59Z,2008-05-16T23:24:20Z,,0,0,09000064804fc9b0
FDA-1988-P-0013-0049,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:21Z,,0,0,0900006480475bb3
FDA-1988-P-0013-0045,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:21Z,,0,0,0900006480475ba6
FDA-1988-P-0013-0048,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:07Z,,0,0,0900006480475bad
FDA-1988-P-0013-0058,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:52:52Z,,0,0,0900006480475bc5
FDA-1988-P-0013-0059,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:21Z,,0,0,0900006480475bc6
FDA-1988-P-0013-0004,FDA,FDA-1988-P-0013,FDA,Notice,NFR-Notice of Final Rule,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:00Z,,0,0,0900006480475b27
FDA-1988-P-0013-0057,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:21Z,,0,0,0900006480475bc4
FDA-1988-P-0013-0060,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:07Z,,0,0,0900006480475bc7
FDA-1988-P-0013-0054,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:52:52Z,,0,0,0900006480475bc0
FDA-1988-P-0013-0061,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:00Z,,0,0,0900006480475bc8
FDA-1988-P-0013-0006,FDA,FDA-1988-P-0013,FDA,Notice,NFR-Notice of Final Rule,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:00Z,,0,0,0900006480475b29
FDA-1988-P-0013-0046,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:28Z,,0,0,0900006480475ba8
FDA-1988-P-0013-0055,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:21Z,,0,0,0900006480475bc2
FDA-1988-P-0013-0040,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:00Z,,0,0,0900006480475b99
FDA-1988-P-0013-0041,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:28Z,,0,0,0900006480475b9c
FDA-1988-P-0013-0053,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:52:52Z,,0,0,0900006480475bbf
FDA-1988-P-0013-0062,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:00Z,,0,0,0900006480475bc9
FDA-1988-P-0013-0047,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:52:36Z,,0,0,0900006480475baa
FDA-1988-P-0013-0051,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:28Z,,0,0,0900006480475bb8
FDA-1988-P-0013-0056,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:14Z,,0,0,0900006480475bc3
FDA-1988-P-0013-0050,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:52:45Z,,0,0,0900006480475bb5
FDA-1988-P-0013-0044,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:52:52Z,,0,0,0900006480475ba3
FDA-1988-P-0013-0043,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:52:45Z,,0,0,0900006480475ba0
FDA-1988-P-0013-0052,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:00Z,,0,0,0900006480475bba
FDA-1995-N-0049-0001,FDA,FDA-1995-N-0049,Beverages: Bottled Water,Notice,NPR-Notice of Proposed Rule-Making,1995-11-29T05:00:00Z,1995,11,1995-11-13T05:00:00Z,1996-01-30T04:59:59Z,2024-07-16T14:08:13Z,95-27799,0,0,0900006480561cac
FDA-1988-P-0013-0005,FDA,FDA-1988-P-0013,FDA,Notice,NFR-Notice of Final Rule,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:21Z,,0,0,0900006480475b28
FDA-1995-N-0049-0002,FDA,FDA-1995-N-0049,"Reference 1 - Humphreys, S., Contaminants, Standards, and Monitoring Branch (HFS-308F), Center for Food Safety and Applied Nutrition, Food and Drug Administration, memo to Shellee Davis, May 26, 1995.",Notice,NPR-Notice of Proposed Rule-Making,1995-11-29T05:00:00Z,1995,11,,,2024-07-16T14:13:41Z,,0,0,0900006480561ccb
FDA-1988-P-0013-0042,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:52:52Z,,0,0,0900006480475b9e
FDA-1988-P-0013-0063,FDA,FDA-1988-P-0013,Background Material for NFR1,Supporting & Related Material,BKG-Background Material,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:52:45Z,,0,0,0900006480475bca
FDA-1995-G-0040-0001,FDA,FDA-1995-G-0040,Amoco Bioproducts Corp.,Notice,NFL-Notice of Filing,1995-11-28T05:00:00Z,1995,11,1995-10-23T04:00:00Z,1996-01-09T04:59:59Z,2008-05-16T22:22:17Z,,0,0,0900006480560ff7
FDA-1995-P-0044-0003,FDA,FDA-1995-P-0044,"FDA/DDM to Westwood Squibb Pharmaceuticals, Inc",Other,ACK-Acknowledgement Letter,1995-11-27T05:00:00Z,1995,11,,,2008-05-16T23:07:30Z,,0,0,090000648056143f
FDA-1980-N-0074-0033,FDA,FDA-1980-N-0074,FDA,Notice,NFR-Notice of Final Rule,1995-11-27T05:00:00Z,1995,11,,,2008-05-30T22:52:47Z,,0,0,09000064805bb3c8
FDA-1980-N-0074-0034,FDA,FDA-1980-N-0074,FDA,Notice,NFR-Notice of Final Rule,1995-11-27T05:00:00Z,1995,11,,,2008-05-30T22:53:02Z,,0,0,09000064805bb3c9
FDA-1978-N-0018-0144,FDA,FDA-1978-N-0018,"Letter from The Assembly State of New York, Albany to FDA",Other,Letter(s),1995-11-22T05:00:00Z,1995,11,,,2019-07-23T18:14:02Z,,0,0,090000648055a251
FDA-1995-P-0023-0001,FDA,FDA-1995-P-0023,HFA-305 to Columbia University of School of Public Health,Other,ACK-Acknowledgement Letter,1995-11-20T05:00:00Z,1995,11,,,2008-05-16T23:07:11Z,,0,0,0900006480559662
FDA-1995-P-0010-0001,FDA,FDA-1995-P-0010,Acknowledgement Letter to American Feed Industry Association and Animal Health Institute,Other,ACK-Acknowledgement Letter,1995-11-14T05:00:00Z,1995,11,,,2013-07-28T01:44:10Z,,0,0,090000648055842e
FDA-1978-N-0018-0143,FDA,FDA-1978-N-0018,"Memorandum of Meeting Between FDA and Givaudan-Roure Corporation et al August 11, 1995",Other,Memorandum,1995-11-01T05:00:00Z,1995,11,,,2019-07-23T16:14:40Z,,0,0,090000648055a248
FDA-1995-P-0042-0001,FDA,FDA-1995-P-0042,Acknowledgment Letter from FDA DMB to Competitive Enterprise Institute,Other,ACK-Acknowledgement Letter,1995-10-31T05:00:00Z,1995,10,,,2025-09-15T16:26:01Z,,0,0,090000648056126b
FDA-1982-P-0001-0011,FDA,FDA-1982-P-0001,FDA/Associate Commissioner for Regulatory Affairs,Other,PDN-Petition Denial,1995-10-27T04:00:00Z,1995,10,,,2008-05-30T22:53:10Z,,0,0,090000648050d497
FDA-1978-N-0018-0142,FDA,FDA-1978-N-0018,"Letter from FDA CDER to the Honorable Audrey I. Pheffer & Harvey Weisenberg, New York State Assembly",Other,Letter(s),1995-10-26T04:00:00Z,1995,10,,,2019-07-23T16:02:30Z,,0,0,090000648055a246
FDA-1995-P-0004-0001,FDA,FDA-1995-P-0004,Acknowledgement Letter from FDA DMB to Bock Pharmacal Co,Other,Acknowledgement Letter/Receipt,1995-10-12T04:00:00Z,1995,10,,,2024-06-06T01:00:29Z,,0,0,09000064805583cb
FDA-1995-S-0039-0050,FDA,FDA-1995-S-0039,"Reference I ""Stevia Abstracts"" Memorandum from FDA/CFSAN",Supporting & Related Material,Background Material,1995-10-05T04:00:00Z,1995,10,,,2016-09-30T14:19:54Z,,0,0,090000648055c206
FDA-1980-N-0074-0032,FDA,FDA-1980-N-0074,"Letter from FDA HFD-811 to Cosmetic, Toiletry and Fragrance Association",Other,Letter(s),1995-10-04T04:00:00Z,1995,10,,,2022-04-21T20:23:50Z,,0,0,09000064805bb362
FDA-1995-S-0039-0001,FDA,FDA-1995-S-0039,Memorandum from FDA/CFSAN,Other,M-Memorandum,1995-09-27T04:00:00Z,1995,9,,,2016-09-30T14:17:47Z,,0,0,090000648055bacf
FDA-1995-N-0031-0004,FDA,FDA-1995-N-0031,"Notice of Proposed rulemaking; extension of comment period re Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug products for Over-The-Counter Human use; proposed amendment of Monograph for OTC Bronchodilator Drug products; Extension of Comment period",Proposed Rule,Extension of Comment Period,1995-09-27T04:00:00Z,1995,9,1995-09-27T04:00:00Z,2008-05-10T03:59:59Z,2016-02-10T16:50:49Z,,0,0,090000648055a8dc
FDA-1995-N-0014-0001,FDA,FDA-1995-N-0014,FDA,Notice,NCR-Notice of Correction,1995-09-25T04:00:00Z,1995,9,1995-09-25T04:00:00Z,1995-10-31T04:59:59Z,2008-05-16T22:22:27Z,,0,0,09000064805584ac
FDA-1995-N-0021-0001,FDA,FDA-1995-N-0021,FDA,Notice,NPR-Notice of Proposed Rule-Making,1995-09-21T04:00:00Z,1995,9,1995-09-21T04:00:00Z,1995-11-07T04:59:59Z,2008-05-16T22:22:34Z,,0,0,09000064805594aa
FDA-1995-G-0001-0001,FDA,FDA-1995-G-0001,"Notice of Filing Solvay Enzymes, Inc. Filing of Petition for Affirmation of GRAS Status",Notice,Notice of Filing,1995-08-31T04:00:00Z,1995,8,1995-08-31T04:00:00Z,1995-11-02T04:59:59Z,2016-04-12T19:31:18Z,,0,0,090000648055830b
FDA-1991-N-0037-0004,FDA,FDA-1991-N-0037,FDA,Notice,NCR-Notice of Correction,1995-08-30T04:00:00Z,1995,8,,,2008-05-16T23:40:33Z,,0,0,0900006480529fdd
FDA-1993-N-0023-0003,FDA,FDA-1993-N-0023,"Neurological Devices; Effective Date of Requirement for Premarket Approval of Cranial Electrotherapy Stimulators; August 24, 1995",Rule,Final Rule,1995-08-29T04:00:00Z,1995,8,,,2011-12-05T20:30:05Z,,0,0,09000064804fafd2
FDA-1991-P-0020-0001,FDA,FDA-1991-P-0020,Letter from FDA to Bass & Ullman on Behalf of National Association of Pharmaceutical Manufacturers,Other,Letter(s),1995-08-28T04:00:00Z,1995,8,,,2023-11-16T21:52:45Z,,0,0,09000064805284a2
FDA-1995-N-0031-0003,FDA,FDA-1995-N-0031,"Notice of Correction re Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human use; Proposed Amendment of Monograph for OTC Bronchodilator Drug Products",Notice,Correction,1995-08-24T04:00:00Z,1995,8,,,2016-02-12T19:14:24Z,,0,0,090000648055a826
FDA-1995-P-0006-0003,FDA,FDA-1995-P-0006,"Acknowledgment Letter from FDA DMB to Mikart, Inc.",Other,Acknowledgement Letter/Receipt,1995-08-21T04:00:00Z,1995,8,,,2025-09-19T00:46:55Z,,0,0,0900006480558400
FDA-1995-P-0006-0002,FDA,FDA-1995-P-0006,"Acknowledgment Letter from FDA DMB to Mikart, Inc.",Other,Acknowledgement Letter/Receipt,1995-08-21T04:00:00Z,1995,8,,,2025-09-19T00:46:31Z,,0,0,09000064805583ff
FDA-1995-P-0006-0004,FDA,FDA-1995-P-0006,"Acknowledgment Letter from FDA DMB to Mikart, Inc.",Other,Acknowledgement Letter/Receipt,1995-08-21T04:00:00Z,1995,8,,,2025-09-19T00:47:17Z,,0,0,0900006480558401
FDA-1995-P-0006-0001,FDA,FDA-1995-P-0006,"Acknowledgment Letter from FDA DMB to Mikart, Inc.",Other,Acknowledgement Letter/Receipt,1995-08-18T04:00:00Z,1995,8,,,2025-09-19T00:45:55Z,,0,0,09000064805583f5
FDA-1995-P-0002-0002,FDA,FDA-1995-P-0002,"HFA-305 to Kleinfeld, Kaplan & Becker",Other,ACK-Acknowledgement Letter,1995-08-11T04:00:00Z,1995,8,,,2008-05-16T23:06:15Z,,0,0,0900006480558353
FDA-1995-P-0360-0002,FDA,FDA-1995-P-0360,Acknowledgement Letter to Citizen Petition from Center for Science in the Public Interest,Other,Acknowledgement Letter/Receipt,1995-08-04T04:00:00Z,1995,8,2015-04-05T04:00:00Z,,2015-04-05T13:56:53Z,,0,0,0900006481a8be2c
FDA-1995-P-0360-0001,FDA,FDA-1995-P-0360,Citizen Petition from Center for Science in the Public Interest,Other,Citizen Petition,1995-08-04T04:00:00Z,1995,8,2015-04-05T04:00:00Z,,2015-04-05T13:57:11Z,,0,0,090000648059a009
FDA-1995-N-0031-0002,FDA,FDA-1995-N-0031,"Notice of Proposed rulemaking re Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug products for Over-The-Counter Human use; Proposed Amendment of Monograph for OTC Bronchodilator Drug products",Proposed Rule,Notice of Proposed Rulemaking (NPRM),1995-08-02T04:00:00Z,1995,8,1995-08-02T04:00:00Z,2008-05-10T03:59:59Z,2016-02-10T16:37:10Z,,0,0,090000648055a7a0
FDA-1995-N-0031-0001,FDA,FDA-1995-N-0031,Notice of Proposed Rulemaking re OTC Bronchodilator Drug Products,Proposed Rule,Notice of Proposed Rulemaking (NPRM),1995-08-02T04:00:00Z,1995,8,1995-08-02T04:00:00Z,1995-08-29T03:59:59Z,2016-02-17T22:00:57Z,,0,0,090000648055a720
FDA-1995-P-0016-0003,FDA,FDA-1995-P-0016,HFA-305,Other,ACK-Acknowledgement Letter,1995-07-28T04:00:00Z,1995,7,,,2008-05-16T23:06:36Z,,0,0,0900006480558657
FDA-1990-N-0002-0006,FDA,FDA-1990-N-0002,FDA,Notice,NM-Notice of Meeting,1995-07-27T04:00:00Z,1995,7,1995-07-27T04:00:00Z,1995-10-24T03:59:59Z,2008-05-16T23:46:02Z,,0,0,090000648052558a
FDA-1995-M-0007-0001,FDA,FDA-1995-M-0007,Tab B: Approval Letter from FDA CDRH to Chiron Vision Corporation,Notice,Notice of Approval,1995-07-27T04:00:00Z,1995,7,1995-07-27T04:00:00Z,1995-08-22T03:59:59Z,2024-06-27T16:33:30Z,,0,0,0900006480558409
FDA-1995-M-0007-0002,FDA,FDA-1995-M-0007,Tab C: Summary of Safety and Effectiveness Data,Notice,Notice of Approval,1995-07-27T04:00:00Z,1995,7,1995-07-27T04:00:00Z,1995-08-22T03:59:59Z,2024-06-27T16:34:56Z,,0,0,090000648055840b
FDA-1995-M-0007-0003,FDA,FDA-1995-M-0007,Chiron Vision Corp.; Premarket Approval of Adatomed Silicone Oil OP5000,Notice,Notice of Approval,1995-07-27T04:00:00Z,1995,7,1995-07-27T04:00:00Z,1995-08-22T03:59:59Z,2024-06-27T16:29:51Z,95-17832,0,0,090000648055840c
FDA-1991-N-0037-0003,FDA,FDA-1991-N-0037,FDA,Notice,NAD-Notice of Availability of Data,1995-07-26T04:00:00Z,1995,7,,,2008-05-16T23:40:33Z,,0,0,0900006480529fda
FDA-1988-V-0025-0001,FDA,FDA-1988-V-0025,Approval for Variance from Laser Images Productions,Other,Approval for Variance (VRA),1995-07-20T04:00:00Z,1995,7,,,2023-12-01T16:06:11Z,,0,0,09000064804763b9
FDA-1995-P-0018-0002,FDA,FDA-1995-P-0018,"Acknowledgment Letter from FDA DMB to Mikart, Inc.",Other,Acknowledgement Letter/Receipt,1995-07-20T04:00:00Z,1995,7,,,2025-07-07T17:49:13Z,,0,0,09000064805592aa
FDA-1995-P-0018-0001,FDA,FDA-1995-P-0018,"Acknowledgment Letter from FDA DMB to Mikart, Inc.",Other,Acknowledgement Letter/Receipt,1995-07-20T04:00:00Z,1995,7,,,2025-10-11T08:00:48Z,,0,0,0900006480559274
FDA-1978-N-0018-0141,FDA,FDA-1978-N-0018,Letter from FDA CDER to Paul Pierce,Other,Letter(s),1995-07-13T04:00:00Z,1995,7,,,2019-07-31T14:03:30Z,,0,0,090000648055a240
FDA-1995-P-0017-0001,FDA,FDA-1995-P-0017,HFS-150 to The Quaker Oats Company,Other,ACK-Acknowledgement Letter,1995-07-06T04:00:00Z,1995,7,,,2008-05-16T23:06:49Z,,0,0,0900006480558802
FDA-1981-F-0038-0001,FDA,FDA-1981-F-0038,Food Additives Permitted for Direct Addition to Food for Human Consumption; Epoxidized Soybean Oil,Notice,Notice of Final Rule,1995-06-29T04:00:00Z,1995,6,1995-06-29T04:00:00Z,1995-07-27T03:59:59Z,2021-03-02T15:20:02Z,95-15349,0,0,09000064805af256
FDA-1981-F-0038-0002,FDA,FDA-1981-F-0038,Background Material re Finding of No Significant Impact,Supporting & Related Material,Background Material,1995-06-26T04:00:00Z,1995,6,,,2021-03-02T15:02:45Z,,0,0,09000064805af258
FDA-1995-P-0041-0001,FDA,FDA-1995-P-0041,"Acknowledgment Letter from FDA DDM to Compressed Gas Association, Inc.",Other,Acknowledgement Letter/Receipt,1995-06-26T04:00:00Z,1995,6,,,2017-02-14T15:24:15Z,,0,0,09000064805611af
FDA-1995-P-0035-0001,FDA,FDA-1995-P-0035,FDA,Notice,NAD-Notice of Availability of Data,1995-06-20T04:00:00Z,1995,6,,,2008-05-16T23:07:26Z,,0,0,090000648055aed4
FDA-1995-P-0051-0004,FDA,FDA-1995-P-0051,Acknowledgment Letter from FDA DMB to Public Citzen Health Research Group,Other,Acknowledgement Letter/Receipt,1995-06-16T04:00:00Z,1995,6,,,2025-09-15T21:41:17Z,,0,0,0900006480561e5c
FDA-2020-D-2006-0001,FDA,FDA-2020-D-2006,"Guidance for Industry: Letter to Manufacturers, Importers, and Distributors of Imported Candy and Candy Wrappers",Other,Guidance,1995-06-13T04:00:00Z,1995,6,2020-09-23T04:00:00Z,,2024-11-06T23:39:05Z,,1,0,09000064848746a5
FDA-1992-N-0049-0002,FDA,FDA-1992-N-0049,Topical Drug Products Containing Benzoyl Peroxide; Required Labeling; Extension of Comment Period,Notice,NEC-Notice of Extension,1995-06-07T04:00:00Z,1995,6,1995-06-07T04:00:00Z,1995-07-18T03:59:59Z,2010-02-25T18:34:06Z,,0,0,090000648052bd0a
FDA-1995-P-0058-0001,FDA,FDA-1995-P-0058,"Acknowledgment Letter from FDA DMB to Lerch, McDaniel & Kauo, PLC",Other,Acknowledgement Letter/Receipt,1995-06-06T04:00:00Z,1995,6,,,2025-09-09T09:00:16Z,,0,0,090000648056c3d3
FDA-1995-P-0015-0001,FDA,FDA-1995-P-0015,"Acknowledgement Letter from FDA HFA-305 to Akin, Grump, Strauss, Hauer & Feld, L.L.P",Other,Acknowledgement Letter/Receipt,1995-05-30T04:00:00Z,1995,5,,,2022-08-17T18:52:38Z,,0,0,0900006480558564
FDA-1978-N-0018-0140,FDA,FDA-1978-N-0018,"Memorandum of Telephone Conversation Between Dr. Weinstock, Brown University & Jeanne Rippere, FDA April 18, 1995",Other,Memorandum,1995-05-11T04:00:00Z,1995,5,,,2019-07-31T14:07:58Z,,0,0,090000648055a230
FDA-1978-N-0018-0139,FDA,FDA-1978-N-0018,"Memorandum of Telephone Conversation Between Dr. J. Ferguson, Boots Contract Manufacturing  & Jeanne Rippere, FDA May 1, 1995",Other,Memorandum,1995-05-11T04:00:00Z,1995,5,,,2019-07-23T13:31:51Z,,0,0,090000648055a22d
FDA-1995-M-0055-0001,FDA,FDA-1995-M-0055,Medtronlc CardloRhythm; Premarket Approval of Atakr Radio Frequency Catheter Ablation System,Notice,Notice of Approval,1995-05-03T04:00:00Z,1995,5,1995-05-03T04:00:00Z,1995-05-31T03:59:59Z,2024-06-12T20:00:38Z,,0,0,090000648056c1d8
FDA-1981-N-0015-0001,FDA,FDA-1981-N-0015,Over-the-Counter Dental and Oral Health Care Drug Products for Antiplaque Use; Safety and Efficacy Review; Request for Data and Information,Notice,Requests for Information (RFI),1995-05-02T04:00:00Z,1995,5,1995-05-02T04:00:00Z,1991-03-19T04:59:59Z,2023-03-31T12:55:51Z,,0,0,09000064805aecdc
FDA-1981-N-0015-0004,FDA,FDA-1981-N-0015,Notice of Extension from FDA/CDER re over the couter dental and oral health care drug products for antiplaque use safty and efficacy review extension of submission period,Notice,Notice of Extension,1995-05-02T04:00:00Z,1995,5,1995-05-02T04:00:00Z,1991-06-18T03:59:59Z,2015-06-09T18:22:26Z,,0,0,09000064805aecfa
FDA-1981-N-0015-0003,FDA,FDA-1981-N-0015,Notice of Extension from FDA CDER re Over the counter dental and oral health care drug products for antiplaque use safty and efficacy review extension of submission period,Notice,Notice of Extension,1995-05-02T04:00:00Z,1995,5,1995-05-02T04:00:00Z,1991-06-18T03:59:59Z,2015-05-27T16:23:27Z,,0,0,09000064805aecf9